StonvexLoading…
StonvexCore line items from MSGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $199.80M | $875.08M | $442.88M | $39.45M | $1.04B |
Operating Income | Not available | $-3.28M | $-5.25M | $-27.43M | $14.81M |
Net Income | Not available | $-20.54M | $-555.00K | $-8.80M | $-22.44M |
EPS (Diluted) | $0.42 | $-0.85 | $-0.02 | $-0.37 | $-0.93 |
Total Assets | Not available | $1.51B | $1.54B | $1.52B | $1.47B |
Total Liabilities | Not available | $1.80B | $1.83B | $1.81B | $1.75B |
Cash & Equivalents | Not available | $107.04M | $81.30M | $48.63M | $144.62M |
Free Cash Flow OCF − CapEx | Not available | $3.64M | $-53.74M | $-85.33M | $87.99M |
Shares Outstanding | Not available | 24.15M | 24.14M | 24.12M | 24.09M |